Recently, pre-clinical studies have demonstrated that phospho-modified ibuprofen (p-ibuprofen) plays a preventative role in the development of colorectal cancer, through the inhibition of NFκB activity [130]. This evidence concerns the gene NFKB1 and colorectal cancer.